A large single-payer administrative claims database was used to assess the economic impact of switching from metoprolol to nebivolol for the treatment of hypertension.
Stephanie Chen, PhD
Advertisement
Articles by Stephanie Chen, PhD
Advertisement
Latest Updated Articles
- Cost Impact of Switching From Metoprolol to Nebivolol for Hypertension
Published: June 22nd 2016 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Therapeutic Cancer Vaccines: Are We There Yet?
2
In the Fragmented Landscape of Long COVID Care, Pharmacists Are Essential
3
FDA Approves Gazyva for Active Lupus Nephritis
4
How More Effective Communication Methods Can Increase Confidence in Vaccines
5
